HRP20021011B1 - Highly concentrated stable meloxicam solutions - Google Patents

Highly concentrated stable meloxicam solutions

Info

Publication number
HRP20021011B1
HRP20021011B1 HR20021011A HRP20021011A HRP20021011B1 HR P20021011 B1 HRP20021011 B1 HR P20021011B1 HR 20021011 A HR20021011 A HR 20021011A HR P20021011 A HRP20021011 A HR P20021011A HR P20021011 B1 HRP20021011 B1 HR P20021011B1
Authority
HR
Croatia
Prior art keywords
highly concentrated
meloxicam
concentrated stable
meloxicam solutions
stable meloxicam
Prior art date
Application number
HR20021011A
Other languages
English (en)
Croatian (hr)
Inventor
Daneck Klaus
Martin
Hassel Bernhard
Henke Stefan
Kroff Hans-Juergen
Kruss Bernd
Prox Axel
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7646375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20021011(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of HRP20021011A2 publication Critical patent/HRP20021011A2/hr
Publication of HRP20021011B1 publication Critical patent/HRP20021011B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20021011A 2000-06-20 2002-12-18 Highly concentrated stable meloxicam solutions HRP20021011B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10030345A DE10030345A1 (de) 2000-06-20 2000-06-20 Hochkonzentrierte stabile Meloxicamlösungen
PCT/EP2001/006904 WO2001097813A2 (fr) 2000-06-20 2001-06-19 Solutions stables fortement concentrees de meloxicam

Publications (2)

Publication Number Publication Date
HRP20021011A2 HRP20021011A2 (en) 2005-02-28
HRP20021011B1 true HRP20021011B1 (en) 2006-02-28

Family

ID=7646375

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20021011A HRP20021011B1 (en) 2000-06-20 2002-12-18 Highly concentrated stable meloxicam solutions

Country Status (32)

Country Link
EP (1) EP1299107B1 (fr)
JP (2) JP2003535902A (fr)
KR (1) KR100805651B1 (fr)
CN (1) CN1236774C (fr)
AR (2) AR028967A1 (fr)
AT (1) ATE297736T1 (fr)
AU (2) AU8185201A (fr)
BG (1) BG65798B1 (fr)
CA (1) CA2414063C (fr)
CZ (1) CZ302717B6 (fr)
DE (2) DE10030345A1 (fr)
EA (1) EA005765B1 (fr)
EC (1) ECSP024371A (fr)
EE (1) EE04930B1 (fr)
ES (1) ES2244643T3 (fr)
HK (1) HK1057859A1 (fr)
HR (1) HRP20021011B1 (fr)
HU (1) HU229184B1 (fr)
IL (2) IL153114A0 (fr)
ME (1) ME00253B (fr)
MX (1) MXPA02012732A (fr)
MY (1) MY137729A (fr)
NO (1) NO330199B1 (fr)
NZ (1) NZ523583A (fr)
PT (1) PT1299107E (fr)
RS (1) RS50142B (fr)
SK (1) SK286938B6 (fr)
TW (1) TWI250018B (fr)
UA (1) UA73584C2 (fr)
UY (1) UY26781A1 (fr)
WO (1) WO2001097813A2 (fr)
ZA (1) ZA200209989B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
EP1348436A1 (fr) * 2002-03-30 2003-10-01 Boehringer Ingelheim International GmbH Suppositoires de meloxicam
JP4707316B2 (ja) * 2002-10-11 2011-06-22 ロート製薬株式会社 水性液状組成物
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (fr) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Utilisation du meloxicam pour le traitement de maladies respiratoires des porcs
DE102004025324A1 (de) * 2004-05-19 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
DK1824493T3 (da) * 2004-12-06 2008-12-08 Janssen Pharmaceutica Nv Oral suspension, der omfatter meloxicam
EP1848270B1 (fr) 2005-02-17 2014-05-21 Abbott Laboratories Administration par voie transmuqueuse de compositions medicamenteuses pour le traitement et la prevention de troubles chez les animaux
CN101584696A (zh) * 2008-05-21 2009-11-25 上海艾力斯医药科技有限公司 包含喹唑啉衍生物的组合物及制备方法、用途
TR200809200A1 (tr) 2008-12-01 2009-12-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Meloksikam içeren farmasötik formülasyonlar
JP5559339B2 (ja) 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
CA2791805A1 (fr) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Utilisation de meloxicam pour le traitement a long terme de troubles musculo-squelettiques chez les chats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
KR101045052B1 (ko) * 2011-01-18 2011-06-28 지수광 자세교정용 발받침대
CN102908310A (zh) * 2012-11-02 2013-02-06 青岛康地恩药业股份有限公司 一种犬、猫用治疗类风湿性关节炎的美洛昔康注射液
CN104983686A (zh) * 2015-07-13 2015-10-21 胡涵 畜禽用美洛昔康可溶性粉剂及其制备方法
CN105213402B (zh) * 2015-09-30 2018-12-18 洛阳市兽药厂 一种畜禽复方恩诺沙星美洛昔康可溶性粉
US20200360268A1 (en) * 2017-08-24 2020-11-19 Jiangsu Hengrui Medicine Co., Ltd. Injectable pharmaceutical composition containing meloxicam, and preparation method therefor
KR20190107481A (ko) * 2018-03-12 2019-09-20 충북대학교 산학협력단 멜록시캄을 포함하는 구강붕해필름 제조방법 및 이에 의해 제조된 멜록시캄을 포함하는 구강붕해필름
JP7374501B2 (ja) * 2018-05-11 2023-11-07 南京清普生物科技有限公司 メロキシカム組成物、製剤及びその製造方法と応用
CN112823786A (zh) * 2019-11-21 2021-05-21 北京泰德制药股份有限公司 一种含有美洛昔康的药物组合物及应用
WO2021224815A1 (fr) * 2020-05-06 2021-11-11 Cadila Healthcare Limited Solutions parentérales aqueuses stables de médicament anti-inflammatoire non stéroïdien (ains)
CN115068419A (zh) * 2022-07-22 2022-09-20 潍坊恒邦兽药有限公司 兽用高浓度美洛昔康注射剂及其加工设备

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
ATE57472T1 (de) * 1984-03-14 1990-11-15 Jerome Corbiere Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
JPH0418022A (ja) * 1990-05-10 1992-01-22 Fujikawa Kk ピロキシカムの安定水溶液ならびにその製造法
HU205550B (en) * 1990-11-27 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pyroxycam solution of increased stability, free from effects damaging tussues
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
ATA156496A (de) * 1996-09-03 1997-10-15 Nycomed Austria Gmbh Pharmazeutische zusammensetzung
EP0945134A1 (fr) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Nouvelles formes galeniques du meloxicam pour administration par voie orale
WO1999059634A1 (fr) * 1998-05-15 1999-11-25 Wakamoto Pharmaceutical Co., Ltd. Gouttes oculaires anti-inflammatoires
WO2001037838A1 (fr) * 1999-11-24 2001-05-31 Wakamoto Pharmaceutical Co., Ltd. Preparation aqueuse ophtalmique
KR200182299Y1 (ko) * 1999-12-08 2000-05-15 장지일 플로스 케이스를 포함하는 플로스 홀더
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen

Also Published As

Publication number Publication date
NO20026132L (no) 2003-02-11
ECSP024371A (es) 2003-02-06
DE10030345A1 (de) 2002-01-10
YU96402A (sh) 2006-01-16
IL153114A (en) 2011-07-31
NO330199B1 (no) 2011-03-07
AU8185201A (en) 2002-01-02
MY137729A (en) 2009-03-31
NO20026132D0 (no) 2002-12-19
EP1299107A2 (fr) 2003-04-09
JP2003535902A (ja) 2003-12-02
PT1299107E (pt) 2005-08-31
AR028967A1 (es) 2003-05-28
KR100805651B1 (ko) 2008-02-26
HU229184B1 (en) 2013-09-30
RS50142B (sr) 2009-03-25
ATE297736T1 (de) 2005-07-15
TWI250018B (en) 2006-03-01
MEP39808A (en) 2011-02-10
EE200200701A (et) 2004-08-16
CN1236774C (zh) 2006-01-18
CA2414063A1 (fr) 2001-12-27
UY26781A1 (es) 2002-01-31
AU2001281852B2 (en) 2006-04-13
IL153114A0 (en) 2003-06-24
ZA200209989B (en) 2003-10-08
HRP20021011A2 (en) 2005-02-28
SK17992002A3 (sk) 2003-04-01
EE04930B1 (et) 2007-12-17
CN1437472A (zh) 2003-08-20
NZ523583A (en) 2004-09-24
HUP0300854A2 (hu) 2003-08-28
EP1299107B1 (fr) 2005-06-15
JP5330347B2 (ja) 2013-10-30
SK286938B6 (sk) 2009-07-06
ME00253B (fr) 2011-05-10
PL359553A1 (en) 2004-08-23
DE60111529D1 (de) 2005-07-21
MXPA02012732A (es) 2004-09-10
WO2001097813A2 (fr) 2001-12-27
AR100293A2 (es) 2016-09-28
JP2010280726A (ja) 2010-12-16
EA200201254A1 (ru) 2003-06-26
UA73584C2 (en) 2005-08-15
DE60111529T2 (de) 2005-12-15
BG65798B1 (bg) 2009-12-31
CZ302717B6 (cs) 2011-09-21
EA005765B1 (ru) 2005-06-30
WO2001097813A3 (fr) 2002-05-10
KR20030013447A (ko) 2003-02-14
ES2244643T3 (es) 2005-12-16
BG107347A (en) 2003-09-30
HK1057859A1 (en) 2004-04-23
CA2414063C (fr) 2008-06-17
CZ20024191A3 (cs) 2003-04-16

Similar Documents

Publication Publication Date Title
HRP20021011B1 (en) Highly concentrated stable meloxicam solutions
YU69902A (sh) Novi derivati piperazina
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
ATE464049T1 (de) Pharmazeutische kombinationen von hydrocodon und naltrexon
CA2273420A1 (fr) Comprime matriciel permettant la liberation prolongee de gliclazide apres administration par voie orale
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
MY130441A (en) Solutions containing epinastin
GR1003658B (el) Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου
MXPA03011480A (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral.
YU46503A (sh) Farmaceutski oblik dronedarona za parenteralnu upotrebu
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
EE200100066A (et) Naatriumkloriidi kasutamine kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsetekõrvaltoimete vähendamiseks
MXPA03008837A (es) Una composicion farmaceutica estable de pravastatina.
HRP20020332B1 (en) Oral solution containing galanthamine and a sweetening agent
PT1299114E (pt) Composicao farmaceutica de diclofenac com base em vitamina e, papina e hialuronidase
DE50005076D1 (de) Pharmazeutische, metamizol enthaltende brauseformulierung
PT1109806E (pt) Complexos de paroxetina com ciclodextrinas ou derivados de ciclodextrinas
ES2149736T1 (es) Composiciones farmaceuticas conteniendo derivados de tienopiridina estables y libres de antioxidantes.
IT1302289B1 (it) Composizioni farmaceutiche ad attivita' antineoplastica
UA38786A (uk) Фібринолітичний засіб
IT1320772B1 (it) Composizione farmaceutica a base di agenti attivi contro la candidaper il trattamento di disturbi della mucosa orale e intestinale
TH59791B (th) สารละลายเมลอกซีแคมที่คงสภาพและความเข้มข้นสูง
TH62584A (th) สารละลายเมลอกซิแคมที่เสถียรชนิดเข้มข้นสูงสำหรับการฉีดแบบไม่ใช้เข็ม
ECSP003349A (es) Derivados de mevinolina

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190607

Year of fee payment: 19

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200617

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20210619